Yahoo

Medical Properties Trust (MPT) Is Up 6.2% After Returning To Quarterly Profitability And Affirming Dividend – Has The Bull Case Changed?

Trade MPT on Coinbase
  • In February 2026, Medical Properties Trust, Inc. reported that fourth-quarter 2025 revenue rose to US$270.34 million and it returned to a US$17.31 million net profit after a very large net loss a year earlier, while full-year 2025 losses narrowed to US$277.05 million on nearly flat revenue of US$972.02 million.

  • The earnings release highlighted an improvement in normalized funds from operations, progress resolving tenant bankruptcies through new long-term hospital leases and restructurings, and a continued focus on paying down debt even as the board affirmed a quarterly dividend of US$0.09 per share.

  • We'll now examine how this return to quarterly profitability and improved funds from operations might reshape Medical Properties Trust's existing investment narrative.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 30 best rare earth metal stocks of the very few that mine this essential strategic resource.

Medical Properties Trust Investment Narrative Recap

To own Medical Properties Trust today, you need to believe that its hospital-focused portfolio can translate improving operations and normalized funds from operations into steadier cash flow despite ongoing tenant and leverage pressures. The return to quarterly profitability and higher NFFO is encouraging, but the key near term catalyst remains the successful ramp up of rent from re-tenanted hospitals, while the biggest current risk is still the REIT's elevated debt load and refinancing needs. The latest results do not remove that risk.

Among recent announcements, the new 15 year lease for six California hospitals, expected to generate US$45 million in annual rent by December 2026, looks especially relevant. This deal sits at the heart of the re-tenanting catalyst, replacing a distressed Prospect relationship with longer term cash flow potential, but it also matters for the leverage story because the timing and reliability of that rent will influence how quickly Medical Properties Trust can reduce its high debt burden.

Yet behind the improved quarter, investors should also be aware of the still very high leverage ratio and looming refinancing needs...

Read the full narrative on Medical Properties Trust (it's free!)

Medical Properties Trust's narrative projects $1.1 billion revenue and $136.7 million earnings by 2028. This requires 3.1% yearly revenue growth and an earnings increase of about $1.5 billion from -$1.4 billion today.

Uncover how Medical Properties Trust's forecasts yield a $5.17 fair value , a 11% downside to its current price.

Exploring Other Perspectives

MPT 1-Year Stock Price Chart
MPT 1-Year Stock Price Chart

While the consensus view stresses balance sheet strain, the most optimistic analysts were already modeling about US$1.1 billion in revenue and roughly US$363 million in earnings by 2028, so this earnings beat could either support their upbeat thesis or prompt them to reassess how much risk you are really taking.

Explore 5 other fair value estimates on Medical Properties Trust - why the stock might be worth over 2x more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

Interested In Other Possibilities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include MPT .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: